With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector supports biotech and pharmaceutical R&D and commercialization by providing lab ...
Morning Overview on MSN
Quantum-powered proteins could launch a shocking new biotech era
Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...
Forensics experts gather DNA to understand who was present at a crime scene. But what if the crime occurred in the middle of ...
Lysosomes are membrane-bound organelles whose acidic lumen (pH 4.5–5.0) is required for degradation. This luminal acidity is ...
After being described in 2018, researchers knew they had something interesting with T3p, a single small RNA found in breast ...
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...
Scientists have developed a new nanoparticle-based strategy that could dramatically expand the range of disease-causing proteins that can be targeted by modern medicine. A newly released perspective i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback